• Medical Devices

Stryker Recalls Modular Neck Stems Action Specific to Rejuvenate and ABG II Modular-Neck Stems

The FDA announced that one of the world’s leading medical technology companies, Styker, voluntarily recalled its Rejuvenate and ABG II modular-neck stems medical devices. The recall was…

By Darren Tobin

/ 12 Jul 2012

• Prescription Drugs

FDA Advisory Panel Meets to Scrutinize the Safety of Metal-On-Metal Hip Implants

Will the FDA issue guidelines in the treatment and monitoring of patients with this device? Many Physicians and patients that our firm have spoken to consistently talk about the lack of…

By M. Brandon Smith

/ 29 Jun 2012

• Prescription Drugs

Propecia Still Being Given Despite the Known Risks

The hair growth drug, Propecia, was first approved in 1997 by the Food and Drug Administration (FDA). When the drug was first introduced into the market, a number of researchers and doctors…

By Darren Tobin

/ 18 Jun 2012

• Legal

Johnson & Johnson Chooses to Discontinue Producing the Ethicon Mesh Implants

Ethicon, a subsidiary of Johnson & Johnson sent letters to the judges in federal and state court overseeing vaginal mesh lawsuits to notify them that the company is going to stop selling the…

By Darren Tobin

/ 13 Jun 2012

• Prescription Drugs

Bronx Jury Awards $120,000,000 to Stevens-Johnson Syndrome Victim

A jury in New York recently awarded close to $120 million to a woman who was diagnosed with Stevens-Johnson Syndrome on May 25, 2012. The amount awarded is one of the largest awards ever issued…

By Darren Tobin

/ 11 Jun 2012

• Medical Devices

Artificial Hips Recalled

British based giant Smith & Nephew recently issued a voluntary recall on a component of one of its all-metal artificial hip systems. The all-metal artificial hip system recall comes after an…

By Darren Tobin

/ 11 Jun 2012

• Prescription Drugs

Actos Conclusively Linked to Cause of Bladder Cancer

The British Medical Journal (BMJ) published an article this week providing evidence for Actos bladder cancer injury lawsuits, finding that the longer a patient takes Actos and the more Actos a…

By Darren Tobin

/ 7 Jun 2012

• Prescription Drugs

New Legislation Proposed to Hold Generic Drug Manufacturers Responsible for Side Effects

Senator Patrick Leahy has recently introduced new legislation in hopes to restore the rights of citizens and hold drug manufacturers of generic brand drugs accountable for failing to warn…

By Darren Tobin

/ 4 Jun 2012

• Legal

Propecia and Proscar Warn of Serious Sexual Problems

Those men who are considering taking the drug finasteride should carefully consider the risk of sexual side effects, according to Consumer Reports. Finasteride is the active ingredient in…

By Darren Tobin

/ 21 May 2012

• Prescription Drugs

Legal Drugs Can Sometimes Be As Deadly as Illegal Drugs – Know What You're Taking

Ever wonder how to find out exactly what inactive ingredients are in medication? Most people do not know or care to know what inactive ingredients are in the drug they are about to take, but some…

By Darren Tobin

/ 21 May 2012

• Medical Devices

CBS Atlanta News Examines The Recalled DePuy ASR Hip Implant With Atlanta Attorney Richard Schlueter

The DePuy ASR hip recall initiated in August of 2010 has been a hot topic of discussion in the medical community over the last year and half. Surprisingly thousands of patients are still unaware…

By M. Brandon Smith

/ 17 May 2012

• Legal

Will Broadspire Pay My DePuy ASR Hip Claim After My Statute of Limitations Expires?

Based on our experiences and conversations, the average client is usually unaware of the level of sophistication a risk management firm such as Broadspire, who has been hired by DePuy…

By M. Brandon Smith

/ 16 May 2012